Home » Lundbeck to Buy Ovation Pharmaceuticals for Up to $900 Million
Lundbeck to Buy Ovation Pharmaceuticals for Up to $900 Million
Denmark’s H. Lundbeck said that it will buy Ovation Pharmaceuticals Inc. for up to $900 million. Lundbeck will make an upfront payment of $600 million upon closing.
MarketWatch
MarketWatch
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May